Peter Piperis, MD
Pain Medicine · Omaha, NENPI 1588690663
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Medtronic at 58.8% of the total. Reporting peaked in 2024 at $1,011 and has fallen 52.5% since, to $480 in 2025. That places this record below the midpoint for pain medicine clinicians in NE, where the typical reported total is $4,468.
Across 105 payments — averaging $38.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$489
- Boston Scientific$209
- AbbVie$204
- SPR Therapeutics, Inc$193
- Si-bone, Inc.$189
- plus $401 from 14 others
What the payments were for
- Food & beverage$4,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 40 | $2,408 |
| Abbott | 14 | $489 |
| Boston Scientific | 12 | $209 |
| AbbVie(2 entities) | 11 | $204 |
| SPR Therapeutics, Inc | 7 | $193 |
| Si-bone, Inc. | 4 | $189 |
| Vertos Medical, Inc. | 2 | $69 |
| Nevro Corp. | 2 | $57 |
| Spinal Simplicity, LLC | 1 | $51 |
| Stryker | 1 | $40 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Biotronik NRO, Inc. | 1 | $23 |
| Medline Industries LP | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Relievant Medsystems, Inc. | 1 | $16 |
| Forte Bio-pharma LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Baudax Bio Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,092 in reported general payments places this provider in the 45th percentile of 31 pain medicine providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $1,094 |
| Pregabalin | 13 | $330 |
| Oxycodone Hcl | 21 | $257 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Omaha
- Matthew StottleOmaha$14K
- Katie BerkyOmaha$12K
- Tyrus SoaresOmaha$8K
- Apollo StackOmaha$8K
- Jess RolandOmaha$8K
- Marshall LaddOmaha$7K
- James DevneyOmaha$5K
- Dan NichollsOmaha$3K
- Ernesto PadronOmaha$3K
- Christopher CriscuoloOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.